SCHEMBL6491906

SCHEMBL6491906

CCCCCOc1ccc(Cn2c(C)nc3ccc(-c4nc(C)c(C(=O)O)[nH]4)cc32)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.45
ALOX5AP P20292 2/20 0.37
GPR17 Q13304 4/20 0.37
BRD4 O60885 1/20 0.36
PIN1 Q13526 1/20 0.36
PDE6D O43924 1/20 0.36
MCL1 Q07820 1/20 0.36
PDE2A O00408 3/20 0.36
VDR P11473 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
PPARA Q07869 1/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
P2RY12 Q9H244 1/20 0.35
RARB P10826 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6488895 0.92 PPARG (0.44) PPARGALOX5APBRD4PDE2AKDM4E
SCHEMBL6489425 0.88 PPARG (0.36) PPARGALOX5APGPR17MCL1KDM4E
SCHEMBL6490563 0.85 PPARG (0.45) PPARGALOX5APBRD4PIN1PDE6D
SCHEMBL6301607 0.84 PPARG (0.58) PPARGRARB
SCHEMBL6303646 0.84 PPARG (0.57) PPARGRARB
SCHEMBL6308005 0.84 PPARG (0.57) PPARGRARB
SCHEMBL6492145 0.84 PPARG (0.51) PPARGALOX5APMCL1PDE2APDE3B
SCHEMBL6303584 0.84 PPARG (0.56) PPARGALOX5APPIN1VDRNR1H4
SCHEMBL6491422 0.82 PPARG (0.51) PPARGALOX5APMCL1PDE2APPARA
SCHEMBL6498744 0.82 PPARG (0.51) PPARGALOX5APMCL1PDE2APDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD PPARG 233/4885ALOX5AP 4663/4885GPR17 813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.